Elicio Therapeutics

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$4.60-$12.62
Market Cap
$138.5M
Shares Short
1M

Financials

See more
Revenue (12 Mos)
$0
Revenue Growth (YoY)
0%
Gross Profit (12 Mos)
$0
Diluted EPS
-$3.11

News

See more

Yahoo Finance • 2 months ago

Elicio Therapeutics Appoints Veteran CMC and Technical Operations Executive Marc J. Wolfgang as Chief Technology Officer

Yahoo Finance • 2 months ago

Elicio Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Updates

Yahoo Finance • 2 months ago

KRAS Inhibitors Market to Witness Explosive Growth at a CAGR of 35% During the Forecast Period (2025–2034) Amid Expanding Therapeutic Landscape | DelveInsight

Yahoo Finance • 4 months ago

Elicio Therapeutics Announces Investigator-Initiated Phase 1 Trial to be Conducted by Memorial Sloan Kettering Cancer Center and funded by The Lustgarten Foundation for Neoadjuvant ELI-002 7P in Pancreatic Ductal Adenocarcinoma

About

CEO
Mr. Robert T. Connelly
Address
451 D Street, Boston, MA, United States, 02210
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
32